Showing results (21-30 of 157) with videos related to
Sort By:
Pageof 16
Rheumatology (Oxford, England)|July 13, 2010
Lack of seroconversion of rheumatoid factor and anti-cyclic citrullinated peptide in patients with early inflammatory arthritis: a systematic literature reviewLillian Barra, Janet Pope, Louis Bessette, et al.The Journal of Rheumatology. Supplement|November 3, 2011
Quality of life issues in pediatric immune-mediated inflammatory diseaseCiarán M Duffy, George A Wells, Anthony S Russell, et al.BMC Musculoskeletal Disorders|November 19, 2011
Safety and effectiveness of adalimumab in a clinical setting that reflects Canadian standard of care for the treatment of rheumatoid arthritis (RA): results from the CanACT studyBoulos Haraoui, Alfred Cividino, Jacqueline Stewart, et al.Rheumatology and Therapy|October 30, 2018
Real-World Tocilizumab Use in Patients with Rheumatoid Arthritis in Canada: 12-Month Results From an Observational, Noninterventional StudyBoulos Haraoui, Shahin Jamal, Vandana Ahluwalia, et al.The Journal of Rheumatology. Supplement|March 3, 2011
Patients considered as having undifferentiated peripheral inflammatory arthritis: a systematic reviewEdith Villeneuve, Bindee Kuriya, Claire BombardierThe Journal of Rheumatology. Supplement|March 3, 2011
Diagnostic and prognostic value of history-taking and physical examination in undifferentiated peripheral inflammatory arthritis: a systematic reviewBindee Kuriya, Edith Villeneuve, Claire BombardierCurrent Rheumatology Reports|September 24, 2009
The role of biomarkers in the management of patients with rheumatoid arthritisJackie Nam, Edith Villeneuve, Paul EmeryThe Journal of Rheumatology|April 3, 2012
Treating rheumatoid arthritis to target: a Canadian physician surveyBoulos Haraoui, William Bensen, Louis Bessette, et al.Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry|January 5, 2013
Biologics and the cardiovascular system: a double-edged swordCamille Roubille, Johanne Martel-Pelletier, Boulos Haraoui, et al.Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry|January 5, 2013
Cardiovascular adverse effects of anti-inflammatory drugsCamille Roubille, Johanne Martel-Pelletier, Jean-Marc Davy, et al.Pageof 16